Gsa Capital Partners LLP Catalent, Inc. Transaction History

Gsa Capital Partners LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$87.2 - $114.05 $184,776 - $241,671	2,119 New	2,119 $227,000
Q4 2019 Feb 12, 2020	SELL	$47.06 - $56.64 $949,247 - $1.14 Million	-20,171 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$47.45 - $58.05 $957,113 - $1.17 Million	20,171 New	20,171 $961,000
Q4 2018 Feb 12, 2019	SELL	$29.95 - $46.34 $280,541 - $434,066	-9,367 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$40.12 - $45.55 $375,804 - $426,666	9,367 New	9,367 $427,000
Q2 2018 Aug 09, 2018	SELL	$38.72 - $42.52 $280,410 - $307,929	-7,242 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$39.4 - $47.39 $245,698 - $295,524	-6,236 Reduced 46.27%	7,242 $297,000
Q4 2017 Feb 14, 2018	SELL	$37.27 - $43.02 $1.47 Million - $1.7 Million	-39,494 Reduced 74.56%	13,478 $554,000
Q3 2017 Nov 20, 2017	BUY	$33.75 - $41.67 $1.79 Million - $2.21 Million	52,972	52,972 $2.12 Million

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.